Twice in the past two years, the National Institute of Health has halted a massive women’s health study. The study known as the Women’s Health Initiative, showed preliminary findings of hormone replacement therapy research ws in direct conflict with previous statements. It has been believed the use of estrogens with proestins had numerous positive effects. Now they determined the combination increases the risks of breast cancer, strokes, heart attacks and blood clots in post-menopausal women. While it showed estrogen protects women from hip fractures, it may also increase their risk of developing dementia or cognitive impairment.
Estrogen only appears to slightly increase the risk of stroke while never fulfilling the promise of protection against heart disease Estrogen by itself increases the risk of uterine cancer and other forms of estrogen based cancers i.e. breast cervical. It is important to recognize that many other forms of cancer or secondary formed cancers have an estrogen base to it. This includes bone, colon, brain, kidney, genitor-urinary to name a few.
A recent study at the
Womens Health Initiative (federally sponsored)- women who take the hormone pill after menopause nearly double their risk of heart attack during the first year. It also found it compounds the risk of those with elevated cholesterol
New England Journal of Medicine found a similar risk of 24% and said the risk during the first year was exceptionally high at 81%
Long term antibiotic use in adolescent females increases risk of E cancer due to destruction of MF that is soil based.
Resulting candida has an influence on E receptor site. May be involved with weight gain
PCOS-Polycystic Ovary Syndrome:
Major contributors are:
Insulin resistance-potential diabetes
Obesity-usually more localized to the abdominal region rather than hips and thighs
Relative high levels of testosterone in relation to estrogen-identified by acne, back or
facial hair growth, inability to lose weight, irregular periods
Low birth weight